Summary by Futu AI
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.